It doesn't take much to push the price of this stock down; and by the same token it doesn't take that much to push the price of this stock up. The problem here is no news....of any sort. If all of a sudden they got funding or there was something positive that speaks to the long-term commercial value of Apabetalone in a significant way then the price will skyrocket from $C0.20. Will that happen? I have no idea but maybe somebody at Eversana does, if they're still actively involved.....whatever that means.  Maybe the major shareholders do. What is clear is that we know squat, and that's why the price is $.20 Canadian.